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Mice Against Ticks is a community-guided ecological engineering project
that aims to prevent tick-borne disease by using CRISPR-based genome edit-
ing to heritably immunize the white-footed mice (Peromyscus leucopus)
responsible for infecting many ticks in eastern North America. Introducing
antibody-encoding resistance alleles into the local mouse population is
anticipated to disrupt the disease transmission cycle for decades. Technol-
ogy development is shaped by engagement with community members
and visitors to the islands of Nantucket and Martha’s Vineyard, including
decisions at project inception about which types of disease resistance to
pursue. This engagement process has prompted the researchers to use
only white-footed mouse DNA if possible, meaning the current project
will not involve gene drive. Instead, engineered mice would be released in
the spring when the natural population is low, a plan unlikely to increase
total numbers above the normal maximum in autumn. Community mem-
bers are continually asked to share their suggestions and concerns, a
process that has already identified potential ecological consequences unanti-
cipated by the research team that will likely affect implementation. As an
early example of CRISPR-based ecological engineering, Mice Against Ticks
aims to start small and simple by working with island communities
whose mouse populations can be lastingly immunized without gene drive.
This article is part of a discussion meeting issue ‘The ecology and evol-
ution of prokaryotic CRISPR-Cas adaptive immune systems’.1. Introduction
The prospect of using CRISPR to solve ecological problems by editing the gen-
omes of wild populations has generated considerable interest [1,2]. Claims of
applications with major potential benefits, some doubtless inflated but others
with working laboratory examples [3], have sparked wide-ranging and
sometimes contentious debates about the role of this area of science in society
[4]. The resulting social, diplomatic and regulatory challenges may be more





































Figure 1. (a) The vast majority of environmental genome editing applications seek to alter a local population of the target species. (b) Because environmental
effects are specific to the organism and alteration, the simplest test may involve releasing edited organisms on mostly uninhabited islands without any form of drive.
This might be followed by inhabited island communities choosing to release organisms, and only then by adding a local drive system to enable mainland com-




2Popular attention has focused on CRISPR-based gene
drive systems, the most powerful of which may be capable
of unilaterally editing entire wild populations of organisms.
Mathematical models predict that ‘self-propagating’ CRISPR
gene drives will spread to most populations of the target
species that are connected by gene flow [5–7], a prediction
supported by the observed spread of the natural P
element gene drive to every wild population of the fruit fly
Drosophila melanogaster on six continents during the middle
half of the twentieth century [8]. Given the history of
human-mediated transport of wild organisms and the
media attention focused on gene drive, it is not unreasonable
to assume that self-propagating CRISPR gene drive systems
will eventually affect all populations of the target species.
Yet very few proposed applications intend to affect an
entire species, and even fewer are considered important
enough to work towards an international agreement on use
without a field trial of the technology. The Anopheles gambiaemosquitoes that are the primary vectors for malaria in
Africa may cause enough harm to catalyse such an agreement
[9]; the same might be true of the human schistosomes
Schistosoma haematobium and S. mansoni and perhaps the
New World screwworm Cochliomyia hominivorax. All other
proposed applications of CRISPR-based genome editing in
wild populations involve altering a specific local population
(figure 1a).
The academic and popular media’s focus on gene drive
can easily distract from discussions about ecological effects
of editing wild organisms. The approach discussed here, in
contrast, focuses first on these ecological effects, only consid-
ering local gene drive as a potential method of introduction
once the effects of mouse immunity are understood.
Alterations can be introduced to populations without any
form of gene drive by simply releasing a sufficiently large
number of organisms carrying the desired change. A strategy









Figure 2. The white-footed mouse Peromyscus leucopus is an important
reservoir of most pathogens transmitted by the deer tick I. scapularis
owing to efficient bidirectional infection. Ecological changes have increased
the number of deer, and therefore the number of ticks, as well as the abun-





3population suppression by releasing multiple sterilized
insects for each wild counterpart; a similar approach with fer-
tile organisms can introduce engineered changes.
Islands are a special case: because there is little gene flow
with larger wild populations that would otherwise dilute an
introduced alteration, it is feasible to stably alter island popu-
lations by releasing edited animals without the complications
of a drive. Because ecosystems are complex and not always
well understood, it may be prudent to test the effects of
specific alterations in isolation before adding the compli-
cation of a drive system. Initial field trials on mostly
uninhabited islands might be followed by communities of
larger, inhabited islands choosing to release edited animals
(figure 1b). If successful, other island or mainland commu-
nities might then choose to add some form of local drive to
alter their own populations.
Our emphasis on the role of communities is deliberate, as
the application of genome editing to the shared environment
is similar to infrastructure development and compulsory
public health measures in creating public goods that can
only be provided for some if provided for many. Because
there is no possibility for residents to opt out of the effects,
such issues can become divisive [10]. Deciding whether,
when, and how to proceed are questions of civic governance
rather than informed consent [2,11].
Once developed, ecotechnology ‘products’ are likely to
be governance options analogous to public health measures
such as iodine supplementation [12], which may in practice
be deployed as commercial ventures with government
oversight. But in the research phase, we believe that ecotech-
nology measures are more similar to non-commercial
infrastructure development, where projects assume one of
many possible forms as determined by key early stage
decisions. Early stage infrastructure decisions, at least in
democratic societies, have been found to be more successful
with early community input [13]. The Mice Against Ticks
project discussed here may serve as an example of what
such involvement might look like during the development
of CRISPR-based ecological engineering projects.
To date, the scientists involved in Mice Against Ticks (J.B,
S.R.T, K.M.E) have sought to (1) understand the role ecological
problems play in local communities, (2) describe a range of
potentially feasible technical options, (3) engage with local
community members to determine which (if any) to pursue,
then (4) develop the technology according to community
preferences. Here, we describe Mice Against Ticks as an exper-
imental effort to iteratively engage members of the community
in an effort to solve a public health problem by using CRISPR
to edit wild animals that serve as reservoirs of disease.
2. Tick-borne disease
Lyme disease is the most frequently reported vector-borne ill-
ness in the USA, infecting over 300 000 Americans each year,
the vast majority of whom live in the Northeast or Upper
Midwest [14]. The causative spirochete bacterium (Borrelia
burgdorferi) is transmitted by the black-legged (deer) tick
Ixodes scapularis, the disease vector in eastern North America.
This same tick also transmits the causative agents of babesio-
sis, anaplasmosis, ehrlichiosis and Powassan encephalitis. All
except Powassan virus are treatable if caught early, but many
cases are undiagnosed, often leading to lifelong complications
such as Lyme arthritis, heart block and radiculitis [15].Tick-borne zoonoses are the result of spillover from an
ecological cycle in which ticks infect mammalian hosts,
which subsequently infect the next generation of ticks
(figure 2) [16]. The white-footed mouse Peromyscus leucopus
is an important reservoir for the pathogens transmitted by
deer ticks. This mouse is easily infected by the spirochetal
agent of Lyme disease as well as all of the other members
of the deer tick microbial guild [17], efficiently serves as a
source of infection for ticks and appears to feed a major pro-
portion of subadult deer ticks in most northeastern US
endemic sites. The density of the tick vector depends primar-
ily on that of deer, which are the third and final
(reproductive) host [18]. Over the past several decades,
social and ecological changes such as fragmented reforesta-
tion and suburbanization have led to an explosion in the
deer population, which has significantly increased the
number of ticks [18], while also favouring white-footed
mice [19,20]. The result has been a dramatic increase in the
number of infected ticks and a correspondingly increased
risk to people. Hence, epidemic tick-borne disease is an
anthropogenic ecological problem.
The islands of Nantucket and Martha’s Vineyard have
some of the highest per capita rates of confirmed and probable
Lyme disease cases in the USA [21]. According to the former
Chairman of Nantucket’s Board of Health, 40% of households
have been directly affected (M Macnab 2016, personal com-
munication). Both islands also have unusually high rates of
babesiosis and other infections, especially Nantucket. Lyme
disease and many of the deer tick microbial guild are also
global health burdens from western Europe to Japan.
Many potential interventions exist to reduce the risk of
Lyme disease or other tick-borne infections. One of us
(S.R.T.) has been working closely with the communities of
Nantucket and Martha’s Vineyard on tick-borne disease
prevention for 30 and 20 years, respectively, and has failed
to persuade communities to commit to any intervention.
Most may be classified as short-term approaches, in which




4in perpetuity; once such actions are relaxed, risk returns
to pre-intervention levels. Short-term interventions include
personal protection (repellents, protective clothing, showers,
tick checks), bait stations, oral vaccination of reservoir hosts
and treating yards with acaricide barrier sprays [22].
No one-time intervention capable of long-lasting effects
has been proposed previously. A vaccine against Lyme
disease approved in 1998 for high-risk individuals aged
15–70 conferred 76% protection [23], but was voluntarily
withdrawn by its manufacturer owing to declining sales
[24]. Efforts to reintroduce this vaccine and to develop an
alternative [25] are underway, but both are estimated to
be perhaps a decade from market and may face strong
opposition from anti-vaccination activists.
Deer reduction has been demonstrated to be effective in
reducing tick densities in physically isolated sites such as
islands and peninsulas, but unless local eradication is
achieved, maintaining the benefits requires annual mainten-
ance to keep the herd size to a target density. Sociopolitical
factors including federal and state laws, private land owner-
ship, opposition to firearms, desire from hunters to preserve
hunting as a hobby and affection for deer tend to prevent
routine adoption of this particular intervention even on
islands where one-time eradication could be feasible. Other
possible long-term approaches, such as deforestation, have
yet to be explored. Integrated pest management can be
highly effective, but economic, social and political challenges
to implementation have combined with ecological changes
such that the epidemic curve for Lyme disease continues to
rise unabated.3. Mice against ticks
Seeking applications that could set a precedent for open,
community-guided ecotechnology development, one of us
(K.M.E.) conceived of heritably immunizing wild white-
footed mouse populations against tick-borne disease using
antibodies derived from natural adaptive immunity. Crucially,
introducing sufficient engineered resistance alleles into an
island white-footed mouse population might reduce the reser-
voir competence of a key host for many decades or even
centuries without requiring any form of gene drive. On an
island, these introduced alleles could be subsequently removed
by trapping animals and reintroducing wild-type organisms,
offering a reversible way of assessing ecological effects.
If a simple version of this type of intervention were suc-
cessful at preventing disease on offshore islands, more
technically sophisticated localized gene drive systems [26]
might enable mainland communities to subsequently immu-
nize their own populations—an example of starting small
and simple before scaling up. Even a partial reduction in
the force of transmission in the natural cycle would likely
provide a major public health benefit.
In consultation with colleagues with expertise in science
and society (including S.W.E), we ran a direction-finding
workshop in December 2015 at MIT to determine whether
the approach was sufficiently promising to justify approach-
ing the island communities of Nantucket and Martha’s
Vineyard, and if so, how best to do so. Attending were
ecologists (including S.R.T.), molecular biologists (including
K.M.E. and J.B.), medical doctors, science policy academics
(including S.W.E.), ethicists (including J.L.), scienceeducators, state and federal regulators, and representatives
from island communities and environmental NGOs.
With respect to molecular biology, the proposed
approaches to introduce heritably resistant mice were
deemed technically feasible on the basis of gene therapy
experiments in which mice given the ability to produce
antibodies were protected against numerous pathogens
[27–34]. Combined with advances in the use of CRISPR for
germline editing, attendees concluded that conferring herita-
ble resistance to tick-borne diseases would be a challenging
engineering problem that would take years to accomplish,
but attainable using current CRISPR editing techniques.
Moreover, heritable resistance was determined to be more
cost-effective at scale than less complex, alternative solutions
like by-hand vaccination and bait-based vaccines, especially
when considering options for mainland communities.
Past studies involving the vaccination of wild white-
footed mice with recombinant OspA, a major B. burgdorferi
protein that induced transmission-blocking immunity, indi-
cated that even inefficiently immunizing an important
reservoir can indeed substantially reduce local mouse and
tick infection rates [35,36]. The attendees jointly concluded
that the options were feasible and would likely be of interest
to the communities of Nantucket and Martha’s Vineyard, and
that the research team should contact the islands’ Boards of
Health to schedule presentations for their board members
and interested community members.
In June 2016, we (J.B., S.R.T. and K.M.E.) presented a var-
iety of technical options to approximately 30 community
members at a Nantucket Board of Health meeting. The fol-
lowing month, we gave the same presentation at a meeting
of the Health Agents from the six towns of Martha’s Vineyard
and separately to a gathering of a 100 residents and island
visitors at the Edgartown library. Videos of two of the three
presentations and subsequent townmeetings are publicly avail-
able on Responsive Science, a site dedicated to documenting
and facilitating community-guided research [37].4. Community engagement from the outset
During the aforementioned meetings, we presented a variety
of technical options to residents and visitors of the islands
of Nantucket and Martha’s Vineyard. The first set of options
concerned the type of mouse immunity. Although mice
are good reservoirs, because they seldom acquire sterilizing
immunity to the deer tick transmitted agents like other
mammals, they can be deliberately immunized. Passive
immunization using anti-OspA abrogated Lyme disease
reservoir competence, demonstrating that antibody alone is
sufficient for this effect [38]. Thus, identifying many such
antibodies and encoding them in the germline should
confer heritable immunization. Antibodies targeting individ-
ual pathogens such as B. burgdorferi should prevent only the
specific associated disease, while conferring resistance
to ticks (if possible with antibodies) could block the trans-
mission of all pathogens transmitted by deer ticks. Mice
could therefore be engineered to be anti-disease, anti-tick or
both (figure 3).
A key advantage of relying on antibodies is that this
class of molecule is already abundant in the environment,
constituting approximately 40% of total serum protein

































Figure 3. Research plan to identify native white-footed mouse antibodies conferring protection against pathogens carried by deer ticks or against deer ticks them-
selves, if tick feeding is in fact antibody-mediated (more testing is required to understand the mechanisms that confer resistance to tick feeding). Antibodies will be
encoded in the germline via CRISPR to confer heritable resistance, and ecological effects tested by introducing engineered mice onto one or more sparsely inhabited
islands prior to decisions by the communities of Nantucket and Martha’s Vineyard. (Online version in colour.)
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Figure 4. Potential designs for encoding antibodies in the germline using only native DNA from white-footed mice. (a) Multiple antibodies can be encoded as
separate light and heavy chains, but the risk of incorrect chain assortment and reduced function rises with each antibody so encoded. (b) Correct antibody pairing
can be ensured by linking heavy and light chains together in a single-chain format (scFv-Fc) using DNA linker sequences from white-footed mice. (c) Tandem scFvs
can be similarly linked, potentially improving binding and reducing the required number of expression units. (d ) The most straightforward expression method
includes a separate promoter for each chain. Our current preference is to use the albumin promoter for liver-specific expression because liver cells already efficiently
secrete biomolecules into serum. (e) Including DNA fragments from white-footed mice that when assembled produce simple molecular functions such as ribosomal
skipping, which may not be found in white-footed mice, might improve expression and consequently resistance. VL, light chain variable region; VH, heavy chain




5be absorbed intact by predators and are subject to rapid
microbial decomposition. As a result, using targeted anti-
bodies to create heritable resistance should result in
many fewer unwanted ecological interactions than would
introducing a type of molecule not normally present in
the ecosystem.
The second set of options concerned the source and
arrangement of the engineered DNA (figure 4). On one end
of the spectrum, it may be possible to generate sufficient
heritable resistance by exclusively incorporating nativewhite-footed mouse DNA fragments, rearranged so as to
recreate molecular functions already present in mice. The
resulting organism would be cisgenic, meaning all of its
DNA sequences would be derived from local populations
of the same species. On the other extreme, directly incorpor-
ating known protective Mus and Homo antibodies against
B. burgdorferi would accelerate development, using viral
processing sequences would likely improve resistance, and
including entire foreign genes such as CRISPR with no




6more efficient by incorporating a form of drive. The research
team described this spectrum of options so that members
of the community could form an opinion and express
their preferences.
In outlining the second set of options (without input from
S.W.E. and J.L.), we believed that many people are more
favourably disposed towards cisgenic than transgenic engin-
eered organisms [40], and that this likely relates to the nearly
universal perception that life is a tree, implying that DNA does
not move between distantly related species. As a way of addres-
sing this incorrect assumption about genetic transfer, we often
ask meeting participants who have eaten beef in the past month
to raise their hands, and then note that 25% of the cow genome
originated in snakes owing to an evolutionarily recent horizon-
tal gene transfer event [41]. But we also make clear that
whatever their reasoning, it is their environment, and so the
decision to alter the environment should also be theirs.
Moving forward, we will work to clarify this message and
interpret feedback with the help of S.W.E. and J.L.
The third set of options concerns the method of introduc-
tion. Because Nantucket and Martha’s Vineyard are islands,
introducing sufficient engineered mice with dominant resist-
ance should result in most descendants exhibiting resistance.
However, the trait should gradually be lost over decades
because it is not anticipated to improve mouse reproduction.
Release could be accomplished all at once or over multiple
years. Importantly, the mouse population need not exceed
the normal yearly maximum at any time. For example, intro-
ducing 300 engineered mice into a field harboring a
population nadir of 100 wild mice in the spring is unlikely
to result in a population greater than the normal maximum
of 500–800 mice in the fall owing to still-extant ecological
pressures such as predation, disease, weather and limited
food availability resulting in negative density dependence
[42]. Nonetheless, predators and prey will be carefully mon-
itored both before and after release to evaluate the
environmental impact of introduced mice. Mouse fitness
and reproductive capacity will be studied through common
garden experiments with laboratory-reared and wild mice
in island environments. To increase survival and promote
mating, we are also experimenting with nest-boxes and
other strategies. This research will inform the number of
mice that are ultimately released.
As an alternative to inundative release, foreign CRISPR
genes could be incorporated to create a local drive system
that would confer an inheritance advantage to the resistance
genes, allowing them to spread from a smaller number of
released animals to a much larger population. We made it
clear that we would not build a self-propagating CRISPR
gene drive under any circumstances [1], as such a construct
would likely spread uncontrolled to the mainland and all
other populations of white-footed mice [7]. However, we
might be able to construct a localized ‘daisy drive’ system
to spread resistance, which would involve releasing orders
of magnitude fewer mice [26]. This could be done using
only DNA present within mice, but in this case the CRISPR
components would be located within commensal bacteria
in the mouse gut, not the mouse’s own cells. We explained
to those who attended our presentations that this method
was still theoretical and may not prove to be possible, but
that we would pursue it for their islands if requested.
We (J.B., S.R.T. and K.M.E.) presented these options at the
first three meetings and then asked for an informal show ofhands to express support for various options. Judging from
the results and subsequent conversations, it appeared that
our presentations resulted in a strong preference for immu-
nizing mice against both Lyme disease and ticks if possible.
We did not ask for a show of hands on the second set of
options, but post-meeting discussions suggested a smaller
majority preferred using only native DNA from white-
footed mice if possible, ruling out a CRISPR-based local
drive. Subsequent meetings have refined these choices in
light of community suggestions and concerns while remain-
ing broadly consistent with the apparent initial preferences.
Experiments for the Mice Against Ticks project did not
begin until after these initial community meetings.
(a) Notable successes and failures of our community
engagement strategy
Though a young project, Mice Against Ticks has already
demonstrated areas of strength, made several mistakes, and
confronted a number of open questions (table 1). Some of
these may be useful for other ecotechnology development
projects.
(b) Project timeline: towards field trials
The island communities of Nantucket and Martha’s Vineyard
are socioeconomically and educationally diverse, with a very
high average level of education suggesting they may be well-
suited to guiding research. In the summers, the year-round
residents are joined by groups of comparatively well-to-do
summer residents and tourists, transiently increasing the
local populations by a factor of 10 and including an unu-
sually high number of prominent scientists. Both islands
have long traditions of New England-specific town hall
democracy. Some summer residents retire to become perma-
nent residents, thereby obtaining the right to vote in matters
of local governance. Nantucket is a single polity, while
Martha’s Vineyard comprises six different towns, one of
which includes the separate island of Chappaquiddick. Ques-
tions of project governance are beyond the scope of this
manuscript; we only note here that the desire of the team
to date has been to engage with existing local institutions.
Once the research team has generated and bred a suffi-
cient number of heritably resistant mice, the ecological
effects of the intervention could be tested in field trials on
small, mostly uninhabited private islands or one large private
island (figure 5), because mice are unlikely to travel between
test sites. The team has already engaged with the owners of
several potential field trial islands. These trials will compare
the effects of releasing resistant mice with the effects of releas-
ing an equivalent number of wild-type mice relative to a
control island with no intervention. Monitoring will be
informed by suggestions from community members and
the results will be analysed by independent experts.
Ecological studies of candidate field trial islands are
ongoing to establish appropriate comparisons to the existing
wealth of data on tick-borne disease ecology on Nantucket
and Martha’s Vineyard (20þ years gathered by S.R.T.). If
and when island(s) are deemed suitable, infrastructure can
be put in place to facilitate limited field trials to observe
gene flow patterns and determine optimal release methods
by releasing wild-caught mice in a variety of circumstances,
including providing them with biodegradable nest-boxes [43].
Table 1. Relevant successes and mistakes of Mice Against Ticks to date.
local guidance Community consultations demonstrated interest in the CRISPR-based genome editing project to alter the shared environment.
Community members were involved in discussions on technological options before experiments began.
local guidance A vocal skeptic on each island has agreed to help channel concerns and criticisms from locals who may not otherwise speak out
local awareness A high school biology teacher on Martha’s Vineyard worked with her class to study the project, created a pamphlet to educate the
community, and the students spoke about the project at a local event
communication The project has received local media coverage in The Inquirer and Mirror, The Martha’s Vineyard Times, The Vineyard Gazette and
local NPR stations, and nationally in The New York Times, The New Yorker, The Wall Street Journal, NPR, PBS NOVA Wonders, CNN
and Last Week Tonight, among others
technical During a community meeting on Nantucket, a community member highlighted one potential short-term consequence of releasing
tick-resistant mice that the research team had not considered, which may ultimately change the community’s preferred release
strategy
communication Recent pithy uses of ‘engineered, but 100% mouse’ by the project team could be perceived as misleading (D Wesemann 2018,
personal communication); best to stick to ‘engineered by shufﬂing native mouse-resistant DNA’ and ‘Peromyscus DNA could be
used to create simple, potentially non-native functions if satisfactory to members of the community’
guidance Discussions between the project team and community members after early community presentations on the use of foreign DNA
may have led to erroneous assumptions by the project team regarding actual community preferences
representation Only a small fraction of the population has attended our events despite numerous advertised local presentations, and how to




7(c) Molecular biology: research achievements and
future directions
To isolate white-footed mouse antibodies against OspA, a
B. burgdorferi antigen [44], we adapted a method for cloning
and expressing antibodies from single isolated B cells [45]
with the guidance and assistance of the Wesemann lab at
Harvard Medical School. For the proof of principle, IgG1þ B
cells from OspA-immunized white-footed mice from a
colony derived from Martha’s Vineyard in 1994 were labelled
with OspA-fluorophore conjugates and sorted by fluor-
escence-activated cell sorting. A single-cell RT-PCR strategy
was employed to amplify Ig heavy and light chain variable
region gene transcripts. Candidate anti-OspA antibodies are
being tested for binding affinity and borreliacidal activity
in vitro and within the infectious tick, and will be followed
by epitope mapping. Assuming tick resistance is antibody
mediated [46,47], candidate anti-tick antibodies will also be
tested for antigen binding affinity and undergo target epitope
binding studies. Each antibody will be purified and injected
into white-footed mice, which will be challenged with
infected ticks to determine the extent of B. burgdorferi
clearance or tick rejection relative to control antibodies.
Multiple antibodies may be expressed from the same cell
type in a variety of formats using solely white-footed mouse
DNA (figure 4), though some of these options require the
rearrangement of native DNA fragments to achieve simple
functions such as ribosome skipping that may not normally
be found in white-footed mice. Current technical plans
involve harnessing the albumin enhancer-promoter [48]. For
each design option, efficacy and phenotypic data will be
presented to members of the community and their represen-
tatives to help determine the final version to be tested in field
trials (figure 5).
Because heritable genome editing has not yet been
achieved in white-footed mice, we will test a variety of
delivery methods for CRISPR-based insertion, includingembryo injection and i-GONAD [49]. We will measure
the extent of resistance in edited offspring, and if judged
sufficient, begin separate outcrossing to captured wild
P. leucopus fusus (an insular endemic of Martha’s Vineyard)
and to P. leucopus noveboracensis (found on Martha’s Vine-
yard, Cuttyhunk and Nantucket) while preserving the
introduced resistance alleles by genotyping.(d) Possible expansion to the mainland
In principle, the same antibody-encoding genes used to
confer resistance on the islands could be efficiently intro-
duced in a mainland town using a CRISPR-based daisy
threshold technology to keep the engineered genes within
its borders [50]. Early laboratory research on daisy threshold
systems in other species of rodents is underway in the Esvelt
lab in consultation with Maori iwis and NGOs in Aotearoa,
New Zealand. If successful in Mus, one or more mainland
communities may be approached to consider whether and
how to pursue research on daisy threshold for the heritable
immunization of white-footed mice, potentially including
another island field trial.
Mice Against Ticks may also be considered a pilot project
or proof of principle for ecological engineering intended to
remove the animal reservoirs of other zoonoses. The methods
used to heritably immunize white-footed mice could be
extended to the rodent reservoirs of hantaviruses (hantavirus
pulmonary syndrome, haemorrhagic fever with renal syn-
drome) or arenaviruses such as those causing Lassa fever or
Bolivian haemorrhagic fever.5. Discussion
When developing a new technology, it is often best to begin
by working on what, at least initially, may be considered a
simple, safe and straightforward application. Mice Against
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8Ticks aims to develop an new way of preventing tick-borne
disease that appears to meet these criteria. Heritably immu-
nizing the white-footed mice thought to be responsible for
infecting more ticks than any other species by harnessing
naturally occurring resistance may be the simplest long-
lasting intervention that may be technically and socially
feasible. Mice Against Ticks is starting small by working
with members of island communities to identify a suitable
alteration capable of delivering nearer-term benefits with-
out the added complexity of CRISPR-based gene drive,
which might be developed and combined with those
same alterations later on for other island or mainland
adoption.
Mice Against Ticks is also a very favourably situated pro-
ject with respect to the goal of developing a new model of
community-guided science, although this aspect of the pro-
ject is still in its early stages of development. Numerous
public health and development projects have employed com-
munity-directed initiatives [51], and at least one earlier
ecological engineering project consulted communities regard-
ing safety testing [52]; our model is distinct in featuring
consultation at the earliest phases of biotechnology develop-
ment. The high level of local expertise available to Nantucket
and Martha’s Vineyard is virtually unmatched; many com-
munity members are likely to know someone with the
technical ability to evaluate at least some of the scientific
details of the project. Combined with their long tradition of
town hall democracy, the islands appear to be highly favour-
able environments in which to experiment with feedback
loops between communities and research design. Once devel-
oped and tested, these strategies might be compared with
others and implemented in progressively more challengingenvironments to determine the limits of community-guided
technology development [53].
Writ large, Mice Against Ticks is an effort to shift research
norms towards greater consideration of consequences at a
much earlier stage of technology development.
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